open access

Vol 13, No 4 (2019)
Review articles
Published online: 2019-09-27
Get Citation

Drug selection in the treatment of breakthrough pain: how the pharmacokinetic profile of drugsis to be translated into clinical practice

Jarosław Woroń
DOI: 10.5603/PMPI.2019.0021
·
Palliat Med Pract 2019;13(4):211-215.

open access

Vol 13, No 4 (2019)
Review articles
Published online: 2019-09-27

Abstract

Breakthrough pain in cancer patients (BTP), also referred to as episodic or incident pain, occurs in a signif-icant proportion of patients with baseline pain (40–60%). It is characterized by rapid intensifying (within tens of seconds or a few minutes) and a strong intensity in the numerical rating scale always above 5 and a limited duration, usually up to about 60 minutes. The choice of the drug for the management of BTP in clinical practice should be based on a profound knowledge of pathophysiology of BTP and pharmacokinetic parameters of the drugs used.

Abstract

Breakthrough pain in cancer patients (BTP), also referred to as episodic or incident pain, occurs in a signif-icant proportion of patients with baseline pain (40–60%). It is characterized by rapid intensifying (within tens of seconds or a few minutes) and a strong intensity in the numerical rating scale always above 5 and a limited duration, usually up to about 60 minutes. The choice of the drug for the management of BTP in clinical practice should be based on a profound knowledge of pathophysiology of BTP and pharmacokinetic parameters of the drugs used.

Get Citation
About this article
Title

Drug selection in the treatment of breakthrough pain: how the pharmacokinetic profile of drugsis to be translated into clinical practice

Journal

Palliative Medicine in Practice

Issue

Vol 13, No 4 (2019)

Pages

211-215

Published online

2019-09-27

DOI

10.5603/PMPI.2019.0021

Bibliographic record

Palliat Med Pract 2019;13(4):211-215.

Authors

Jarosław Woroń

References (9)
  1. Dobrogowski J, Wordliczek J. Leczenie bólu. Wydawnictwo Lekarskie PZWL, Warszawa 2017.
  2. Malec-Milewska M, Woroń J. Kompendium leczenia bólu. Medical Education, Warszawa 2017.
  3. Hanna M, Żylicz Z. Cancer Pain. Springer, New York 2014.
  4. Novotna S, Valentova K, Fricova J, et al. ETHYFYL Study Group. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer. Clin Ther. 2014; 36(3): 357–367.
  5. Woroń J. Chory na nowotwór. Interakcje analgetyków i leków stosowanych w terapii objawów współtowarzyszących. Medical Education, Warszawa 2019.
  6. Chisholm–Burns MA, Schwinghammer TL, Malone PM. Pharmacotherapy Principles & Practice. Mc Graw Hill Education, New York 2019.
  7. Rosenthal LD, Burchum JR. Pharmacotherapeutics for Advances Practice Providers. Elsevier, St. Louis 2018.
  8. DiPiro JT, Talbert LR, Yee GC. Pharmacotherapy, a Pathophysiologic Approach. Mc Graw Hill Education, New York 2017.
  9. Wirfs MJ. Prescribing Drug Therapy. Springer Publishing Company, New York 2019.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Medycyna Paliatywna w Praktyce dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl